Lab 4: CBC with Differential
Why it matters: Complete blood count with differential tracks immune system function. TB-500's parent protein (thymosin beta-4) is produced by the thymus and plays a role in T-cell development. Monitoring white blood cell counts and differential ensures the immune system isn't being over-stimulated or suppressed.
WBC
4.0-8.0 x10^3/uL
< 3.5 or > 11.0
Neutrophils
40-60%
> 70% or < 35%
Lymphocytes
20-40%
> 50% or < 15%
Platelets
150-400 x10^3/uL
< 100 or > 450
What to expect: CBC should remain within normal limits throughout a Wolverine Stack cycle. Significant shifts in WBC count or differential could indicate immune dysregulation — unlikely but worth monitoring given TB-500's thymic origin.
Lab 5: IGF-1 (Growth Factor Monitoring)
Why it matters: BPC-157 and TB-500 do not directly affect IGF-1. However, many users stack the Wolverine Stack with GH-releasing peptides (Ipamorelin, CJC-1295) or GH secretagogues (MK-677). If you're stacking, IGF-1 monitoring is essential to ensure growth hormone levels stay within safe ranges.
100-250 ng/mL
Normal (age-dependent)
250-350 ng/mL
Elevated — may be fine if using GH peptides
> 350 ng/mL
High — consider reducing GH peptide dose
If not stacking: You can skip this test. BPC-157 and TB-500 alone should not meaningfully alter IGF-1.
If stacking with GH peptides: Test baseline and at weeks 4-6. IGF-1 above 350 ng/mL warrants dose reduction of the GH component.
Lab 6: P1NP (Tissue Repair Marker)
Why it matters: Procollagen type I N-terminal propeptide (P1NP) is a direct marker of collagen synthesis — essentially a readout of how actively your body is building new connective tissue. Both BPC-157 (via growth factor activation) and TB-500 (via cell migration to repair sites) should support increased collagen formation.
25-100 ng/mL
Normal (age/sex dependent)
> 100 ng/mL
Active tissue remodeling
Significant increase from baseline
Healing peptides are working
What to expect: P1NP should increase from baseline during an active healing protocol. A 20-50% increase suggests active tissue remodeling. If P1NP doesn't budge after 6 weeks, the healing response may be insufficient — consider dose adjustment or protocol review.
Testing note: P1NP is not a standard lab. Request it specifically or order through a specialty lab panel.
Interpreting Your Results
Best Case Scenario
hs-CRP drops 20-40% from baseline
ESR trends downward
Liver enzymes stable or improved
CBC unchanged
P1NP increases (active tissue repair)
Concerning Patterns
hs-CRP increases during cycle — may indicate infection or tissue stress, not peptide-related
ALT/AST rises above 50 — pause protocol, retest in 2 weeks
WBC count drops below 3.5 or rises above 11 — discontinue and consult physician
Any unexpected lab shift that doesn't resolve within 2 weeks
When Bloodwork Should Change Your Protocol
hs-CRP rising
Investigate other causes (infection, overtraining) — not typical of Wolverine Stack
ALT > 50 U/L
Pause protocol 2 weeks, retest. If normalized, resume at lower dose
ALT > 100 U/L
Discontinue, consult physician
WBC < 3.5 or > 11
IGF-1 > 350 (if stacking)
Reduce GH peptide dose
No change in P1NP after 8 weeks
Reassess dose, protocol adherence, or whether the stack targets your specific issue
When to Stop Based on Bloodwork
Red flags that mean discontinue immediately and consult a physician:
ALT or AST > 3x upper limit (>120 U/L) — potential liver damage
WBC < 2.5 x10^3/uL — immune suppression risk
Platelets < 100 x10^3/uL — bleeding risk
Any rapidly worsening lab value between tests
These scenarios are rare with the Wolverine Stack — BPC-157 has shown no hepatotoxicity in clinical trials and TB-500 hasn't demonstrated immune suppression in animal studies. But monitoring catches problems before they become serious.